Genelabs regulatory update

GNLB’s Genelabs Diagnostics unit received a $2.5 million five-year grant from the National Science and Technology Board of Singapore to assist in the development of a rapid diagnostic test for multi-analytes to detect hepatitis, sexually transmitted disease infections, cardiovascular disorders, cancer and other conditions simultaneously. ...